SAN DIEGO --(BUSINESS WIRE)--Apr. 1, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, April 29, 2021 . Management will hold a conference call to review the company's first quarter 2021 performance

SAN DIEGO --(BUSINESS WIRE)--Mar. 23, 2021-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief Financial Officer. In his expanded role, Mr.

SAN DIEGO --(BUSINESS WIRE)--Feb. 17, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences: Quentin Blackford , Chief Operating Officer and Chief Financial Officer, will present on behalf of

Dexcom Ventures to identify and invest in transformational technologies to advance long-term growth SAN DIEGO --(BUSINESS WIRE)--Feb. 11, 2021-- DexCom, Inc. (Nasdaq: DXCM), the global leader in continuous glucose monitoring for people with diabetes, today announced the launch of Dexcom Ventures .

SAN DIEGO --(BUSINESS WIRE)--Feb. 11, 2021-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2020 . Fourth Quarter 2020 Financial Highlights: Revenue grew 23% versus the same quarter of the prior year to $568.9 million

Partnership brings important diabetes conversation to one of the world’s biggest stages Ad raises awareness of Dexcom continuous glucose monitoring as newer, better technology replacing painful fingerpricks In the face of a socially distanced Super Bowl Sunday, Dexcom is also giving fans the

SAN DIEGO --(BUSINESS WIRE)--Jan. 19, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, February 11, 2020 . Management will hold a conference call to review the company's fourth quarter

SAN DIEGO --(BUSINESS WIRE)--Jan. 11, 2021-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2020 to meet or exceed $567 million , an increase of 23% over the

SAN DIEGO --(BUSINESS WIRE)--Jan. 5, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer , Chairman, President and Chief Executive Officer, will present an update on the company at the 39 th annual J.P. Morgan Healthcare Conference on January 11, 2021 .